155 related articles for article (PubMed ID: 38658967)
21. Serum transforming growth factor β and leucine-rich α-2-glycoprotein 1 as potential biomarkers for diagnosis of uterine leiomyomas.
Kamalipooya S; Zarezadeh R; Latifi Z; Nouri M; Fattahi A; Salemi Z
J Gynecol Obstet Hum Reprod; 2021 Mar; 50(3):102037. PubMed ID: 33307240
[TBL] [Abstract][Full Text] [Related]
22. miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma.
Lou N; Ruan AM; Qiu B; Bao L; Xu YC; Zhao Y; Sun RL; Zhang ST; Xu GH; Ruan HL; Yuan CF; Han WW; Shi HC; Yang HM; Zhang XP
Urol Oncol; 2017 Jan; 35(1):36.e7-36.e14. PubMed ID: 27633984
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Accuracy of Leucine-Rich α-2-Glycoprotein 1 as a Non-Invasive Salivary Biomarker in Pediatric Appendicitis.
Tintor G; Jukić M; Šupe-Domić D; Jerončić A; Pogorelić Z
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047015
[TBL] [Abstract][Full Text] [Related]
24. Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles.
Govindarajan A; Salgia NJ; Li H; Castro DV; Mirzapoiazova T; Armstrong B; Zhao D; Mercier BD; Dizman N; Chawla N; Zengin Z; Meza L; Tripathi N; Sayegh N; Chehrazi-Raffle A; Tripathi A; Pal SK
Front Immunol; 2023; 14():1182581. PubMed ID: 37638025
[TBL] [Abstract][Full Text] [Related]
25. Serum Adiponectin Level May be an Independent Predictor of Clear Cell Renal Cell Carcinoma.
Wang H; Wu J; Gu W; Wang B; Wan F; Dai B; Zhang H; Shi G; Shen Y; Zhu Y; Zhu Y; Ye D
J Cancer; 2016; 7(10):1340-6. PubMed ID: 27390609
[TBL] [Abstract][Full Text] [Related]
26. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
[TBL] [Abstract][Full Text] [Related]
27. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
[TBL] [Abstract][Full Text] [Related]
28. Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma.
White NM; Masui O; Desouza LV; Krakovska O; Metias S; Romaschin AD; Honey RJ; Stewart R; Pace K; Lee J; Jewett MA; Bjarnason GA; Siu KW; Yousef GM
Oncotarget; 2014 Jan; 5(2):506-18. PubMed ID: 24504108
[TBL] [Abstract][Full Text] [Related]
29. Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker.
Kim KH; Lee HH; Yoon YE; Na JC; Kim KS; Han WK
Investig Clin Urol; 2019 Nov; 60(6):425-431. PubMed ID: 31692952
[TBL] [Abstract][Full Text] [Related]
30. The predictive and prognostic values of serum amino acid levels for clear cell renal cell carcinoma.
Zhang F; Ma X; Li H; Guo G; Li P; Li H; Gu L; Li X; Chen L; Zhang X
Urol Oncol; 2017 Jun; 35(6):392-400. PubMed ID: 28188089
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of increased preoperative serum high sensitive C-reactive protein and procalcitonin levels on grade and stage of clear cell renal cell carcinoma.
Hamidi N; Gökçe MI; Süer E; Baltaci S
Clin Nephrol; 2015 Apr; 83(4):225-30. PubMed ID: 25707457
[TBL] [Abstract][Full Text] [Related]
32. Serum extracellular vesicles contain SPARC and LRG1 as biomarkers of colon cancer and differ by tumour primary location.
Zhong ME; Chen Y; Xiao Y; Xu L; Zhang G; Lu J; Qiu H; Ge W; Wu B
EBioMedicine; 2019 Dec; 50():211-223. PubMed ID: 31753726
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.
Mytsyk Y; Borys Y; Tumanovska L; Stroy D; Kucher A; Gazdikova K; Rodrigo L; Kruzliak P; Prosecky R; Urdzik P; Dosenko V
Clin Exp Med; 2019 Nov; 19(4):515-524. PubMed ID: 31440867
[TBL] [Abstract][Full Text] [Related]
34. FDG PET/CT and CT Findings of Renal Cell Carcinoma With Sarcomatoid Differentiation.
Zhu H; Zhao S; Zuo C; Ren F
AJR Am J Roentgenol; 2020 Sep; 215(3):645-651. PubMed ID: 32755159
[No Abstract] [Full Text] [Related]
35. Leucine-rich α2-glycoprotein-1 upregulation in plasma and kidney of patients with lupus nephritis.
Yang Y; Luo R; Cheng Y; Liu T; Dai W; Li Y; Ge S; Xu G
BMC Nephrol; 2020 Apr; 21(1):122. PubMed ID: 32252660
[TBL] [Abstract][Full Text] [Related]
36. Leucine-Rich Alpha-2-Glycoprotein 1 in Serum Is a Possible Biomarker to Predict Response to Preoperative Chemoradiotherapy for Esophageal Cancer.
Nambu M; Masuda T; Ito S; Kato K; Kojima T; Daiko H; Ito Y; Honda K; Ohtsuki S
Biol Pharm Bull; 2019; 42(10):1766-1771. PubMed ID: 31582665
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.
Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X
Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
[TBL] [Abstract][Full Text] [Related]
39. YRNA Expression Profiles are Altered in Clear Cell Renal Cell Carcinoma.
Nientiedt M; Schmidt D; Kristiansen G; Müller SC; Ellinger J
Eur Urol Focus; 2018 Mar; 4(2):260-266. PubMed ID: 28753785
[TBL] [Abstract][Full Text] [Related]
40. PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance.
Filipović J; Bosić M; Ćirović S; Životić M; Dunđerović D; Đorđević D; Živković-Perišić S; Lipkovski A; Marković-Lipkovski J
Diagn Pathol; 2019 Oct; 14(1):120. PubMed ID: 31655611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
